Crossmark Global Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $394K | Buy |
1,412
+234
| +20% | +$67.4K | 0.01% | 918 |
|
|
2025
Q4 | $357K | Buy |
+1,178
| New | +$368K | 0.01% | 956 |
|
|
2025
Q3 | – | Sell |
-1,003
| Closed | -$242K | – | 1295 |
|
|
2025
Q2 | $242K | Buy |
1,003
+37
| +4% | +$8.75K | ﹤0.01% | 1192 |
|
|
2025
Q1 | $235K | Buy |
966
+123
| +15% | +$37K | ﹤0.01% | 1194 |
|
|
2024
Q4 | $277K | Sell |
843
-384
| -31% | -$130K | 0.01% | 1072 |
|
|
2024
Q3 | $411K | Sell |
1,227
-595
| -33% | -$189K | 0.01% | 949 |
|
|
2024
Q2 | $498K | Buy |
1,822
+97
| +6% | +$28.2K | 0.01% | 837 |
|
|
2024
Q1 | $597K | Sell |
1,725
-152
| -8% | -$50K | 0.01% | 786 |
|
|
2023
Q4 | $606K | Sell |
1,877
-30
| -2% | -$9.4K | 0.01% | 766 |
|
|
2023
Q3 | $696K | Buy |
1,907
+21
| +1% | +$8.1K | 0.02% | 683 |
|
|
2023
Q2 | $786K | Sell |
1,886
-285
| -13% | -$116K | 0.02% | 665 |
|
|
2023
Q1 | $1.04M | Sell |
2,171
-258
| -11% | -$121K | 0.02% | 574 |
|
|
2022
Q4 | $1.02M | Buy |
2,429
+368
| +18% | +$149K | 0.03% | 562 |
|
|
2022
Q3 | $859K | Sell |
2,061
-112
| -5% | -$55.8K | 0.02% | 585 |
|
|
2022
Q2 | $1.08M | Buy |
2,173
+270
| +14% | +$141K | 0.03% | 545 |
|
|
2022
Q1 | $1.07M | Sell |
1,903
-150
| -7% | -$90.4K | 0.02% | 597 |
|
|
2021
Q4 | $1.55M | Sell |
2,053
-2,650
| -56% | -$1.98M | 0.03% | 501 |
|
|
2021
Q3 | $3.51M | Sell |
4,703
-360
| -7% | -$270K | 0.08% | 252 |
|
|
2021
Q2 | $3.26M | Sell |
5,063
-140
| -3% | -$85.2K | 0.08% | 265 |
|
|
2021
Q1 | $2.97M | Sell |
5,203
-800
| -13% | -$474K | 0.07% | 275 |
|
|
2020
Q4 | $3.5M | Buy |
6,003
+3,560
| +146% | +$2.03M | 0.09% | 250 |
|
|
2020
Q3 | $1.26M | Buy |
2,443
+400
| +20% | +$203K | 0.04% | 467 |
|
|
2020
Q2 | $922K | Buy |
2,043
+218
| +12% | +$96.2K | 0.03% | 557 |
|
|
2020
Q1 | $640K | Sell |
1,825
-70
| -4% | -$25.7K | 0.02% | 585 |
|
|
2019
Q4 | $701K | Sell |
1,895
-400
| -17% | -$141K | 0.02% | 669 |
|
|
2019
Q3 | $764K | Sell |
2,295
-104
| -4% | -$33.9K | 0.02% | 615 |
|
|
2019
Q2 | $750K | Sell |
2,399
-142
| -6% | -$42.5K | 0.02% | 633 |
|
|
2019
Q1 | $777K | Buy |
2,541
+110
| +5% | +$29.7K | 0.02% | 626 |
|
|
2018
Q4 | $565K | Sell |
2,431
-402
| -14% | -$108K | 0.02% | 719 |
|
|
2018
Q3 | $887K | Sell |
2,833
-153
| -5% | -$47.5K | 0.02% | 655 |
|
|
2018
Q2 | $862K | Sell |
2,986
-194
| -6% | -$53.6K | 0.02% | 664 |
|
|
2018
Q1 | $795K | Sell |
3,180
-412
| -11% | -$105K | 0.02% | 688 |
|
|
2017
Q4 | $857K | Sell |
3,592
-445
| -11% | -$108K | 0.02% | 697 |
|
|
2017
Q3 | $897K | Buy |
+4,037
| New | +$908K | 0.02% | 652 |
|
|
2016
Q3 | $897K | Buy |
+4,037
| New | +$613K | 0.02% | 652 |
|
Other funds holding BIO
VCM
VPM
AI
